A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against cancer cells in specific patient groups.

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.

OU Health marked a significant breakthrough for Oklahoma in lung cancer treatment, becoming the first health care system in ...

A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.

These findings could pave the way for new treatment approaches for cancers driven by RAS mutations. Researchers at the ...

The UChicago Medicine team will be led by Odunsi as co-principal investigator and includes Christopher Weber, Savas Tay, and ...

Researchers from Auburn University, partnering with the University of Basel in Switzerland, have discovered a new way to make ...

The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, ...